CC BY 4.0 · Am J Perinatol
DOI: 10.1055/a-2527-4638
Original Article

Improved Growth Velocity Using a New Liquid Human Milk Fortifier in Very Low Birth Weight Infants: A Multicenter, Retrospective Study

Fernando Moya
1   Betty Cameron Children's Hospital and University of North Carolina Medical School, Wilmington, North Carolina
,
Jennifer Fowler
2   East Carolina University Health Medical Center, Greenville, North Carolina
,
Adrian Florens
3   Department of Neonatology, Kidz Medical Services, Palm Beach Children's Hospital, Palm Beach, Florida
,
Jennifer Dombrowski
3   Department of Neonatology, Kidz Medical Services, Palm Beach Children's Hospital, Palm Beach, Florida
,
Olivia Davis
3   Department of Neonatology, Kidz Medical Services, Palm Beach Children's Hospital, Palm Beach, Florida
,
Tiffony Blanks
1   Betty Cameron Children's Hospital and University of North Carolina Medical School, Wilmington, North Carolina
,
Austin Gratton
4   Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina
› Institutsangaben
Funding This retrospective study was supported by Research Grant 8716 from Mead Johnson Nutrition (MJN). The authors independently established the study design, conducted the collection and analysis of data, and made all final decisions to submit a manuscript for publication. MJN reviewed and provided comments on the final draft of the manuscript.

Abstract

Objective

This study aimed to compare growth outcomes and tolerance among very low birth weight (VLBW) infants receiving a new, liquid human milk fortifier (LHMF-NEW) or a human milk fortifier-acidified liquid (HMF-AL).

Study Design

Retrospective, multicenter study of 515 VLBW infants in three regional neonatal intensive care units. The primary objective was to compare growth velocity (g/kg/d) during fortification between groups by repeated measures regression. Secondary outcomes of interest were feeding tolerance and the incidence of late-onset sepsis, necrotizing enterocolitis, and metabolic acidosis. Student's t, analysis of variance, Wilcoxon, and Kruskal–Wallis tests were used for numeric variables, or chi-squared and Fisher's exact test for categorical variables.

Results

No demographic differences were identified between the groups (HMF-AL, n = 242; LHMF-NEW, n = 273). Growth velocity during fortification was significantly higher in the group receiving LHMF-NEW, despite relatively similar total fluid, calorie, or protein intake (p = 0.001). Feeding intolerance was comparable between fortifiers. Necrotizing enterocolitis and late-onset sepsis did not differ between groups and metabolic acidosis was diagnosed less frequently with the LHMF-NEW. Anthropometric measures at discharge and length of stay were comparable.

Conclusion

Infants receiving human milk fortified with the LHMF-NEW had faster growth velocity during fortification, similar tolerance, and less metabolic acidosis compared with an earlier cohort of infants who received human milk fortified with an HMF-AL.

Key Points

  • Among VLBW infants, using an LHMF-NEW resulted in a faster growth velocity in weight during several weeks of fortification than using the previous HMF-AL.

  • The incidence of feeding intolerance (stopping feeds >8 hour) in any given week of fortification was low and not different between groups. Also, late-onset sepsis and necrotizing enterocolitis were uncommon with no differences between groups, whereas the incidence of metabolic acidosis was lower in infants receiving the LHMF-NEW.

  • No differences in length of stay or anthropometrics at discharge were identified.

Authors' Contributions

F.M. designed the study, analyzed the data, and helped to write the manuscript. J.F. collected the data and helped to write the manuscript. A.F. collected the data and helped to write the manuscript. J.D. collected the data and helped to write the manuscript. O.D. collected the data and helped to write the manuscript. T.F. collected the data and helped to write the manuscript. A.G. analyzed the data and helped to write the manuscript.


Supplementary Material



Publikationsverlauf

Eingereicht: 11. Juli 2024

Angenommen: 13. Januar 2025

Accepted Manuscript online:
29. Januar 2025

Artikel online veröffentlicht:
06. März 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Silveira RC, Corso AL, Procianoy RS. The influence of early nutrition on neurodevelopmental outcomes in preterm infants. Nutrients 2023; 15 (21) 4644
  • 2 Chiang KV, Sharma AJ, Nelson JM, Olson CK, Perrine CG. Receipt of breast milk by gestational age—United States 2017. MMWR Morb Mortal Wkly Rep 2019; 68 (22) 489-493
  • 3 Perrin MT, Belfort MB, Hagadorn JI. et al. The nutritional composition and energy content of donor human milk: a systematic review. Adv Nutr 2020; 11 (04) 960-970
  • 4 Parker MG, Stellwagen LM, Noble L, Kim JH, Poindexter BB, Puopolo KM. Section on Breastfeeding, Committee on Nutrition, Committee on Fetus and Newborn. Promoting human milk and breastfeeding for the very low birth weight infant. Pediatrics 2021; 148 (05) e2021054272
  • 5 Arslanoglu S, Boquien CY, King C. et al. Fortification of human milk for preterm infants: update and recommendations of the European Milk Bank Association (EMBA) Working Group on human milk fortification. Front Pediatr 2019; 7: 76
  • 6 Sullivan S, Schanler RJ, Kim JH. et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156 (04) 562-7.e1
  • 7 O'Connor DL, Kiss A, Tomlinson C. et al; OptiMoM Feeding Group. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial. Am J Clin Nutr 2018; 108 (01) 108-116
  • 8 Adamkin DH. Use of human milk and fortification in the NICU. J Perinatol 2023; 43 (05) 551-559
  • 9 Fu TT, Poindexter BB. Human milk fortification strategies in the neonatal intensive care unit. Clin Perinatol 2023; 50 (03) 643-652
  • 10 Jensen GB, Domellöf M, Ahlsson F, Elfvin A, Navér L, Abrahamsson T. Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial. EClinicalMedicine 2024; 68: 102375
  • 11 Moya F, Sisk PM, Walsh KR, Berseth CL. A new liquid human milk fortifier and linear growth in preterm infants. Pediatrics 2012; 130 (04) e928-e935
  • 12 Kim JH, Chan G, Schanler R. et al. Growth and tolerance of preterm infants fed a new liquid extensively hydrolyzed human milk fortifier. J Pediatr Gastroenterol Nutr 2015; 61 (06) 665-671
  • 13 Gates A, Marin T, De Leo G, Waller JL, Stansfield BK. Nutrient composition of preterm mother's milk and factors that influence nutrient content. Am J Clin Nutr 2021; 114 (05) 1719-1728
  • 14 Schanler RJ, Groh-Wargo SL, Barrett-Reis B. et al. Improved outcomes in preterm infants fed a liquid nonacidified human milk fortifier: a prospective, randomized clinical trial. J Pediatr 2018; 202: 31-37.e2
  • 15 Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59
  • 16 Fenton TR, Anderson D, Groh-Wargo S, Hoyos A, Ehrenkranz RA, Senterre T. An attempt to standardize the calculation of growth velocity of preterm infants-evaluation of practical bedside methods. J Pediatr 2018; 196: 77-83
  • 17 Bell MJ, Ternberg JL, Feigin RD. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (01) 1-7
  • 18 Hair AB, Blanco CL, Moreira AG. et al. Randomized trial of human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in infants 750-1250 g birth weight. J Pediatr 2014; 165 (05) 915-920
  • 19 O'Connor DL, Gibbins S, Kiss A. et al; GTA DoMINO Feeding Group. Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: a randomized clinical trial. JAMA 2016; 316 (18) 1897-1905
  • 20 Ozer Bekmez B, Kose Cetinkaya A, Buyuktiryaki M, Alyamac Dizdar E, Sari FN. Do preterm infants with bronchopulmonary dysplasia have a unique postnatal weight gain pattern?. J Matern Fetal Neonatal Med 2023; 36 (02) 2231121
  • 21 Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK. for the National Institute of Child Health and Human Development Neonatal Research Network. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006; 117 (04) 1253-1261
  • 22 Svenningsen NW, Lindquist B. Incidence of metabolic acidosis in term, preterm and small-for-gestational age infants in relation to dietary protein intake. Acta Paediatr Scand 1973; 62 (01) 1-10
  • 23 Schwartz GJ, Haycock GB, Edelmann Jr. CM, Spitzer A. Late metabolic acidosis: a reassessment of the definition. J Pediatr 1979; 95 (01) 102-107
  • 24 Rochow N, Jochum F, Redlich A. et al. Fortification of breast milk in VLBW infants: metabolic acidosis is linked to the composition of fortifiers and alters weight gain and bone mineralization. Clin Nutr 2011; 30 (01) 99-105
  • 25 Paul M, Partridge J, Barrett-Reis B. et al. Metabolic acidosis in preterm infants is associated with a longer length of stay in the neonatal intensive care unit. PharmacoEconom Open 2020; 4 (03) 541-547
  • 26 Lainwala S, Kosyakova N, Spizzoucco AM, Herson V, Brownell EA. Clinical and nutritional outcomes of two liquid human milk fortifiers for premature infants. J Neonatal Perinatal Med 2017; 10 (04) 393-401
  • 27 Cordova EG, Soldateli B, Rosner B. et al. Growth and clinical outcomes of very low-birth-weight infants receiving acidified vs nonacidified liquid human milk fortifiers. Nutr Clin Pract 2021; 36 (06) 1304-1311
  • 28 Darrow CJ, Bai-Tong SS, Kang EM, Thompson CL, Walsh MC. Use of acidified versus non-acidified liquid human milk fortifier in very low birth weight infants: a retrospective comparison of clinical outcomes. J Neonatal Perinatal Med 2020; 13 (01) 71-79
  • 29 Thoene M, Lyden E, Weishaar K. et al. Comparison of a powdered, acidified liquid, and non-acidified liquid human milk fortifier on clinical outcomes in premature infants. Nutrients 2016; 8 (08) 451
  • 30 Wynter Z, Gorham JA, Thompson AB, Mundy C, Waller JL, Stansfield BK. Immediate fortification of human milk with a bovine milk-derived human milk fortifier in very low birth weight infants: a randomized clinical trial. J Perinatol 2024; 44 (11) 1591-1596
  • 31 Salas AA, Gunawan E, Nguyen K. et al. Early human milk fortification in infants born extremely preterm: a randomized trial. Pediatrics 2023; 152 (03) e2023061603
  • 32 Mara KC, Clark RH, Carey WA. Necrotizing enterocolitis in very low birth weight neonates: a natural history study. Am J Perinatol 2024; 41 (S01, suppl S1): e435-e445
  • 33 Shah SD, Dereddy N, Jones TL, Dhanireddy R, Talati AJ. Early versus delayed human milk fortification in very low birth weight infants-a randomized controlled trial. J Pediatr 2016; 174: 126-131.e1